ZWINT Knockout cell line (MIA PaCa-2) – Genotype Verified & Ready-to-use

Red cotton OmniCell bank

10000⁺

Gene Knockout Cell Lines

2000⁺

Luc/EGFP/Cas9 Tool Cell Lines

1000⁺

Wild-type Cell Lines

ZWINT Knockout cell line (MIA PaCa-2)

Copy Product Info

Catalog#

YKO-HA417175

Species

Human

Target Cell Line

MIA PaCa-2

Size

1*10^6

Gene

ZWINT

Storage conditions

Shipped on dry ice; Store in liquid nitrogen

Overview

Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.

ZWINT (ZW10 interacting kinetochore protein) encodes a kinetochore-associated protein involved in chromosome segregation during mitosis. ZWINT interacts with ZW10 and is recruited to kinetochores during prophase before ZW10, remaining detectable through late anaphase. Its localization and interactions suggest a role in kinetochore assembly or regulation and in proper chromosome movement during cell division. The precise molecular mechanisms by which ZWINT supports kinetochore function remain incompletely characterized.

A human pancreatic cancer model, MIA PaCa-2 originated from a primary pancreatic carcinoma of a 65-year-old male. The cells are classified as a human pancreatic cancer cell line and exhibit epithelial characteristics. MIA PaCa-2 has been extensively characterized by genomic and transcriptomic profiling and is represented in major cancer cell line resources.

Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

KO Cell Construction Strategy

Adopting Red Cotton CRISPR Gene Editing Designer (www.rc-crispr.com), two sgRNAs targeting the ZWINT gene are designed to generate a knockout strategy. The two sgRNA sequences are subsequently cloned into the EZ-editor™ vector and introduced into MIA PaCa-2 cells via electroporation or lentiviral transduction. Single-cell clones are then generated using the limiting dilution method. Genomic DNA from individual clones is subjected to nucleic acid lysis and PCR amplification using the EZ-editor™ Monoclone Genotype Validation Kit (Cat# YK-MV-1000). The edited loci are further verified by Sanger sequencing to confirm the genotype. After secondary validation and quality confirmation, ZWINT Knockout cell line (MIA PaCa-2) is expanded and cryopreserved for downstream applications.

Product Overview

ZWINT Knockout cell line (MIA PaCa-2)

The ZWINT Knockout cell line (MIA PaCa-2) is generated by targeted disruption of the ZWINT gene in MIA PaCa-2 cells. This cell line is designed to investigate the role of ZWINT in cellular function and gene regulation, as well as its potential involvement in disease-related pathways.

KO Cell Line

ZWINT Knockout cell line (MIA PaCa-2)

Gene ID

11130

Catalog

YKO-HA417175

Gene Name

ZWINT

Product Category

Knockout(KO) Cell Line

Gene Information

NCBI

Species

Human

Mycoplasma test

Negative

Cell Morphology

Epithelial-like, adheren

Catalog Status

-

Culture method

87.5%DMEM+10%FBS+2.5%HS

Shipping

Cryopreserved Cells shipped in dry ice

Passage ratio

1：2-1：3

Storage Condition

Liquid nitrogen

Quality Control

All KO cell products are tested and confirmed to be free of bacterial, viral, mycoplasma contamination, and other adventitious agents.

Applications

For research use only. Not intended for use in diagnostic, therapeutic, clinical, or other applications.

Key Advantages

Easy to use

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations

High-efficient KO

These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.

Curated cells

Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Quality Control Specifications

1. Bacteria and Fungi Test

None Detected.

2. Mycoplasma test

Negative.

3. STR Authentication

Download STR Report

Intended use

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use

Unpacking and Storage Instructions

1.

Cell Reception

2.

Unpacking and storage instructions

Handling procedure

1.

Cell Thawing

2.

Cell Passaging

3.

Cell cryopreservation

References

More

FAQ

Q1. How to Contact Support if Issues Arise After Receiving the KO Cells?

If any abnormalities are observed after receiving the cells, please provide the following information based on the stage of use and contact us promptly for assistance:

(1) Issues upon delivery: Please provide photos of the cells at the time of receipt along with a brief description of the issue. We will offer after-sales support accordingly.

(2) Issues after thawing or passaging: Please provide microscopic images of the cells before and after thawing/passaging, along with a detailed description of the experimental procedures. Our technical team will provide professional support.

Q2. What Information Is Required When Reporting KO Cell Product Issues?

Q3. How Should the KO cell Product Be Stored Upon Receipt?

Q4. Shipping Method

Q5. Are the Knockout Cell Lines Stable for Passaging? Is Authentication Provided?